| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥2412.4B | ¥2371.9B | +1.7% |
| Operating Income | ¥41.6B | ¥47.9B | -13.1% |
| Ordinary Income | ¥14.7B | ¥30.2B | -51.5% |
| Net Income | ¥-261.3B | ¥31.0B | +7.0% |
| ROE | -40.3% | 3.3% | - |
FY2025 results showed Revenue of ¥241.2B (YoY +1.7%), Operating Income of ¥4.2B (-13.1%), Ordinary Income of ¥1.5B (-51.5%), and Net Income of ¥-26.1B attributable to owners (-893.8%). The sharp decline in profitability was driven by a one-time impairment loss of ¥29.8B recorded as extraordinary loss. Despite the bottom-line loss, Operating Cash Flow remained positive at ¥11.4B (+5.4% YoY), demonstrating continued cash generation capability from core operations. The company projects full-year FY2026 Revenue of ¥246.8B (+2.3%), Operating Income of ¥10.5B (+152.2%), and Net Income of ¥5.0B, indicating expected recovery from non-recurring charges.
Revenue increased 1.7% to ¥241.2B, driven by International Beverage segment growth of 16.1% to ¥65.3B and Pharmaceutical Related segment expansion of 2.4% to ¥13.4B. Geographic analysis reveals Japan revenue declined 2.5% to ¥175.8B, while Turkey grew substantially to ¥45.7B (+16.3%) and Poland expanded to ¥14.3B (+16.4%). The Domestic Beverage segment, representing 59.0% of total revenue, contracted 3.3% to ¥142.7B and reported operating loss of ¥2.3B (margin -1.6%), deteriorating from ¥1.0B profit in prior year. This structural profitability challenge in the core domestic business significantly constrained overall operating performance. International Beverage segment demonstrated strong operating leverage with margin expanding to 11.6% from 9.0% YoY, contributing operating income of ¥7.5B (+48.5%).
Gross profit margin declined to 45.2% from 46.1% YoY as cost of sales increased faster than revenue growth. SG&A expenses rose to ¥104.8B (ratio 43.5%) from ¥104.5B (44.1%), including goodwill amortization of ¥0.7B and depreciation of ¥11.1B. Operating income decreased 13.1% to ¥4.2B with operating margin compressing to 1.7% from 2.0%. Non-operating net expenses increased to ¥2.7B from ¥1.8B, primarily due to higher interest expense of ¥0.8B and FX losses of ¥0.5B, partially offset by interest and dividend income of ¥1.4B. The gap between ordinary income (¥1.5B) and net income (¥-26.1B) is explained by extraordinary loss of ¥29.8B, almost entirely comprised of impairment loss on fixed assets.
The impairment charge of ¥29.8B was concentrated in the Domestic Beverage segment, reflecting asset write-downs due to prolonged underperformance. After income tax expense of ¥3.5B (effective rate -12.7% due to tax on loss), net income attributable to owners was ¥-30.3B. This represents a "revenue up, profit down" pattern, with the profit decline driven by both operational margin compression in domestic business and one-time non-recurring impairment.
Domestic Beverage segment generated revenue of ¥142.7B (-3.3% YoY) with operating loss of ¥2.3B (margin -1.6%), representing the largest business by revenue (59.0% share) but a significant profitability drag. International Beverage segment posted revenue of ¥65.3B (+16.1%) with operating income of ¥7.5B (margin 11.6%), emerging as the primary profit contributor with 48.5% YoY income growth. Pharmaceutical Related segment reported revenue of ¥13.4B (+2.4%) and operating income of ¥0.8B (margin 6.2%), tripling profit from ¥0.3B prior year (+199.3%). Food segment recorded revenue of ¥19.6B (-5.2%) with operating income of ¥0.5B (margin 2.5%), declining 57.9% YoY. DyDo Pharma segment contributed ¥0.6B revenue with operating loss of ¥0.3B (margin -53.0%). The stark margin differential between International Beverage (11.6%) and Domestic Beverage (-1.6%) highlights a structural competitiveness gap in the domestic market requiring urgent operational restructuring.
[Profitability] ROE was -40.3% (vs. prior year 4.2%), reflecting the impact of large net loss on equity base. Operating margin compressed to 1.7% from 2.0%, indicating core business profitability pressure. Net profit margin deteriorated to -10.8% from 1.6% YoY, primarily due to impairment charges. EBITDA was approximately ¥15.3B with EBITDA margin of 6.3%. [Cash Quality] Cash and deposits totaled ¥28.0B with short-term investment securities of ¥11.6B, providing liquid assets of ¥39.6B. Short-term debt coverage ratio (liquid assets to current liabilities) was 0.71x. Operating CF to net income ratio was -0.44x due to negative net income, though operating CF remained positive at ¥11.4B. [Investment Efficiency] Asset turnover was 1.48x, slightly below the industry median of 1.52x. Total assets decreased to ¥162.8B from ¥185.2B (-12.1%), primarily driven by property, plant and equipment reduction of ¥25.1B (-41.8%) reflecting impairment and asset disposals. [Financial Health] Equity ratio was 39.9% (vs. 50.5% prior year and industry median 54.4%), declining due to retained earnings decrease from ¥93.0B to ¥61.4B (-34.0%). Current ratio was 168.2% and debt-to-equity ratio was 1.51x. Net debt to EBITDA was 0.97x, within manageable levels. BPS decreased to ¥2,028.83 from ¥2,908.51, reflecting equity erosion from losses.
Operating CF of ¥11.4B represents a healthy 0.98x conversion from operating CF subtotal before working capital of ¥15.9B, though the ratio to net income is not meaningful given the net loss. Operating activities generated ¥11.4B after absorbing income taxes paid of ¥4.5B and including non-cash impairment charges of ¥29.8B. Investing CF was ¥-12.1B, primarily consisting of CapEx of ¥12.7B, purchase of subsidiaries stock ¥6.7B, and short-term investment securities purchases ¥11.5B, partially offset by proceeds from sales and redemption of securities ¥0.9B and time deposit maturities. Free Cash Flow was ¥-0.7B (Operating CF ¥11.4B minus Investing CF ¥12.1B), indicating investment activities slightly exceeded operational cash generation. Financing CF contributed ¥0.3B, comprised of long-term loan proceeds of ¥12.4B and short-term loan increase of ¥0.3B, offset by bond redemption of ¥10.0B, long-term loan repayment of ¥4.7B, short-term loan decrease of ¥3.0B, and dividend payments of ¥1.3B. Cash and equivalents decreased by ¥1.8B from ¥29.6B to ¥27.9B after ¥1.4B negative FX effect. The CapEx to depreciation ratio was 1.14x, suggesting maintenance-level investment. Working capital movements were relatively neutral with inventory decrease contributing ¥0.7B and payables increase adding ¥3.9B, partially offset by receivables increase of ¥2.6B. The combination of positive operating CF and controlled investment maintains liquidity adequacy despite bottom-line loss.
Ordinary income of ¥1.5B versus operating income of ¥4.2B reflects non-operating net expense of ¥2.7B, comprising interest expense ¥0.8B, FX losses ¥0.5B, and other non-operating expenses ¥0.7B, partially offset by interest and dividend income ¥1.4B and other non-operating income ¥0.6B. Non-operating expenses represent 1.1% of revenue, a reasonable level for a company with international operations and debt financing. The critical earnings quality concern is the extraordinary loss of ¥29.8B (impairment loss), which dwarfs the ordinary income and represents 12.4% of revenue. This one-time charge is non-cash and reflects asset write-downs in the Domestic Beverage segment. Excluding this extraordinary item, profit before tax would have been positive ¥5.0B. Operating CF of ¥11.4B significantly exceeds operating income of ¥4.2B, primarily due to the add-back of non-cash impairment charges in the indirect CF calculation. The large divergence between reported net loss (¥-26.1B) and positive operating CF (¥11.4B) indicates that core business cash generation remains intact despite accounting losses. However, the sustained negative operating margin in Domestic Beverage raises concerns about sustainable profitability. The impairment charge suggests prior period earnings may have overstated economic performance due to inflated asset values. Overall earnings quality is weak due to operating margin pressure and dependence on non-recurring gains/losses, though cash flow provides some reassurance of underlying business viability.
Full-year FY2026 guidance projects Revenue of ¥246.8B (+2.3%), Operating Income of ¥10.5B (+152.2%), Ordinary Income of ¥8.4B (+472.5%), and Net Income of ¥5.0B (recovery from ¥-26.1B loss). Current progress rates cannot be calculated as this is annual reporting. The dramatic operating income recovery forecast (+¥6.3B improvement) implies successful turnaround in Domestic Beverage segment and absence of recurring impairment charges. The guidance assumes ¥10.5B operating income on ¥246.8B revenue, yielding 4.3% operating margin—a significant improvement from current 1.7% that requires validation through quarterly execution. Dividend forecast of ¥15.00 per share implies payout ratio of 9.5% on forecasted EPS of ¥157.73, down from 33.2% historical ratio, reflecting conservative capital allocation during recovery phase. The forecast appears achievable if impairment was truly one-time and operational improvements materialize in domestic business, but execution risk remains substantial given the structural challenges demonstrated in current results.
Annual dividend per share was ¥30.00 (interim ¥15.00 + year-end ¥15.00), unchanged from prior year ¥30.00. Given the net loss of ¥-30.3B, the mathematical payout ratio calculation yields a negative figure, though the company reports 33.2% payout ratio in its data, likely referencing a normalized earnings base or prior commitments. Total dividend payment of ¥1.3B was covered by operating cash flow of ¥11.4B (8.7x coverage), indicating cash generation capacity supports dividend despite accounting loss. The company forecasts ¥15.00 dividend for FY2026 on expected EPS of ¥157.73, implying 9.5% payout ratio and suggesting conservative capital allocation during recovery. No share buyback activity was reported. The maintenance of dividend during a loss year demonstrates management's commitment to shareholder returns and confidence in cash flow sustainability, though the reduced forecast payout ratio indicates prioritization of balance sheet recovery and operational restructuring over aggressive returns.
Domestic Beverage segment structural unprofitability poses the most critical risk, with operating loss of ¥2.3B and negative 1.6% margin on ¥142.7B revenue (59.0% of company total). This core business deterioration threatens group profitability and may require extensive restructuring, capacity rationalization, or strategic alternatives. The segment also absorbed the ¥29.8B impairment charge, indicating prolonged underperformance and potential for additional asset write-downs if turnaround efforts fail.
Foreign exchange and overseas operational risk is significant given International Beverage contributes 27.1% of revenue with major exposure to Turkey (¥45.7B, 18.9% of total) and Poland (¥14.3B, 5.9%), where currency volatility, inflation, and geopolitical factors may impact profitability. The company reported FX losses of ¥0.5B in non-operating expenses and ¥2.3B positive FX translation adjustment in OCI, demonstrating material currency impacts.
Balance sheet deterioration risk is evidenced by equity ratio decline to 39.9% from 50.5%, long-term debt increase of ¥7.9B (+112.8%) to ¥14.8B, and retained earnings decrease of ¥31.6B (-34.0%). The combination of negative earnings, increased leverage, and reduced equity cushion constrains financial flexibility for strategic investments or to absorb future shocks. Continued losses would further erode capital adequacy and potentially trigger covenant concerns or limit access to capital markets.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE -40.3% (Industry Median 6.0%, IQR 2.6%-11.7%), Operating Margin 1.7% (Industry Median 5.0%, IQR 3.3%-8.4%), Net Profit Margin -10.8% (Industry Median 3.2%, IQR 1.9%-6.6%). The company's profitability metrics fall significantly below industry medians, reflecting operational challenges in Domestic Beverage and one-time impairment impact.
Financial Health: Equity Ratio 39.9% (Industry Median 54.4%, IQR 47.8%-64.8%), Current Ratio 168.2% (Industry Median 183.0%, IQR 141.0%-215.0%). Financial health indicators are below industry median but within acceptable ranges, though equity ratio deterioration warrants attention.
Efficiency: Asset Turnover 1.48x (Industry Median 0.92x, IQR 0.70-1.08), indicating relatively efficient asset utilization. Operating Working Capital Turnover approximately 81 days compared to industry median 49 days, suggesting working capital efficiency below peer average.
Growth: Revenue Growth YoY 1.7% (Industry Median 5.4%, IQR 1.0%-8.6%), placing the company below median growth trajectory. EPS Growth YoY -893.8% (Industry Median 10.0%) due to impairment-driven loss.
Cash Generation: Cash Conversion Ratio 0.44x based on Operating CF/Net Income, though this metric is distorted by negative net income. FCF Yield 0.0% (slightly negative) vs Industry Median 3.0%, reflecting investment phase and profitability pressures.
The company ranks below industry median on most profitability and growth metrics, attributable to domestic market challenges and restructuring phase. Asset efficiency remains a relative strength, while financial health indicators warrant monitoring given equity erosion.
(※ Industry: Food & Beverage (27 companies), Comparison: 2025-FY, Source: Proprietary analysis)
The one-time impairment charge of ¥29.8B in the Domestic Beverage segment represents a decisive accounting recognition of structural challenges, creating a reset of asset base and potential foundation for recovery. This non-cash charge does not impair cash generation, as evidenced by positive operating CF of ¥11.4B, suggesting the underlying business continues to generate cash despite weak profitability. The key observation is the stark divergence between International Beverage's 11.6% margin and Domestic Beverage's -1.6% margin, indicating a dual-speed business model where international expansion is succeeding while domestic operations require fundamental restructuring.
Management's FY2026 guidance projects operating margin recovery to 4.3% from 1.7%, implying either successful domestic turnaround or continued shift toward higher-margin international business. The aggressive operating income recovery forecast (+¥6.3B or +152%) will serve as a critical test of strategic execution and credibility. The reduction in forecasted dividend payout ratio to 9.5% from historical 33.2% reflects prioritization of balance sheet repair and operational investment over shareholder distributions during the recovery phase.
Capital structure shows controlled deterioration with equity ratio declining to 39.9% but remaining adequate, while long-term debt increased ¥7.9B to support investments and operations. The company maintains liquidity with ¥39.6B in cash and short-term investments against ¥56.0B current liabilities, providing 0.71x coverage. The combination of negative FCF (¥-0.7B) and dividend maintenance (¥1.3B) suggests near-term cash preservation may become necessary if operational improvement lags.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.